key: cord-0727368-y6a9qfum
authors: Pauley, E. E.; Drake, T. M.; Griffith, D.; Lone, N. I.; Harrison, E. M.; Baillie, J. K.; Scott, J. T.; Walsh, T. S.; Semple, M. G.; Docherty, A. B.
title: Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial
date: 2021-06-21
journal: nan
DOI: 10.1101/2021.06.15.21258879
sha: 4e2acb8f24baf359bfd2cf9eba061ea09b49ad27
doc_id: 727368
cord_uid: y6a9qfum

Background We aimed to compare the prevalence and severity of fatigue in survivors of Covid-19 versus non-Covid-19 critical illness, and to explore potential associations between baseline characteristics and worse recovery. Methods We conducted a secondary analysis of two prospectively collected datasets. The population included was 92 patients who received invasive mechanical ventilation (IMV) with Covid-19, and 240 patients who received IMV with non-Covid-19 illness before the pandemic. Follow-up data was collected post-hospital discharge using self-reported questionnaires. The main outcome measures were self-reported fatigue severity and the prevalence of severe fatigue (severity >7/10) 3 and 12-months post-hospital discharge. Results Covid-19 IMV-patients were significantly younger with less prior comorbidity, and more males, than pre-pandemic IMV-patients. At 3-months, the prevalence (38.9% [7/18] vs. 27.1% [51/188]) and severity (median 5.5/10 vs. 5.0/10) of fatigue was similar between the Covid-19 and pre-pandemic populations respectively. At 6-months, the prevalence (10.3% [3/29] vs. 32.5% [54/166]) and severity (median 2.0/10 vs. 5.7/10) of fatigue was less in the Covid-19 cohort. In the Covid-19 population, women under 50 experienced more severe fatigue, breathlessness, and worse overall health state compared to other Covid-19 IMV-patients. There were no significant sex differences in long-term outcomes in the pre-pandemic population. In the total sample of IMV-patients included (i.e. all Covid-19 and pre-pandemic patients), having Covid-19 was significantly associated with less severe fatigue (severity <7/10) after adjusting for age, sex, and prior comorbidity (adjusted OR 0.35 (95%CI 0.15-0.76, p=0.01). Conclusion. Fatigue may be less severe after Covid-19 than after other critical illness.

(severity <7/10) after adjusting for age, sex, and prior comorbidity (adjusted OR 0.35 (95%CI 0.15-0.76, p=0.01).

Conclusion. Fatigue may be less severe after Covid-19 than after other critical illness.

Post Intensive Care Syndrome (PICS) describes the constellation of physical, psychological and cognitive symptoms affecting 25% of critical illness survivors, which include fatigue, muscle weakness, and posttraumatic stress 1 . PICS may persist for longer than 5 years and is associated with high hospital resource use and readmission rates 2 .

Implementation of post-ICU rehabilitation guidelines is inconsistent, and the best ways to support intensive care unit (ICU) survivors are uncertain [3] [4] [5] ; Identifying those at greatest risk of PICS and providing evidence-based strategies to enhance their recovery remain priorities for critical care research 5 . The Covid-19 pandemic heralded a dramatic increase in ICU admissions, over half of whom survived to discharge, thus a vast new cohort of patients at risk of PICS has emerged 6, 7 .

Many patients who survive acute-Covid-19 experience persistent symptoms beyond 4 weeks, known as 'long-Covid' 8 . This includes a wide range of symptoms, such as breathlessness, fatigue, muscle pain, many of which overlap with PICS and other post-viral syndromes 1, [9] [10] [11] [12] [13] [14] [15] [16] . The most common symptom of long-Covid described following both community and hospital-managed acute-Covid-19 was fatigue: fatigue was reported in 97.7% of community-managed cases who reported symptoms lasting over 28 days, and in 83% and 98% of UK and China patients respectively greater than 3-months after hospital . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.15.21258879 doi: medRxiv preprint discharge following admission with acute-Covid-19 11, 16, 17 . Recent studies have shown requiring invasive mechanical ventilation (IMV) is associated with experiencing worse fatigue and other recovery, but have lacked appropriate controls to compare 'long-Covid' to recovery from all critical illness 9, 11, 12 .

The prevalence of fatigue in ICU-survivors ranges from 13.8% to 80.9% 18 . This has a profound negative impact on survivors' quality of life (QOL), and is one of the most prevalent and debilitating challenges of ICU-survivorship 18, 19 . Fatigue may lead to delayed return to employment and pre-critical illness physical fitness, difficulty in completing activities of daily living, social isolation, depression, and many other negative sequalae [18] [19] [20] .

It is unclear if recovery is different in survivors of Covid-19 critical illness compared to other critical illness, requiring distinct risk assessment tools or interventions to support their recovery.

We aimed to characterise the prevalence and severity of fatigue in Covid-19 ICUsurvivors, compared to survivors of non-Covid-19 critical illness, and to explore potential associations between baseline characteristics and fatigue severity in these populations to identify potential groups at greater risk.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

This was a secondary analysis of two prospectively collected datasets.

Clinical Characterisation Protocol -United Kingdom (ISARIC-4C CCP-UK):

Patients aged 18 years and over, admitted to hospital between 17 th January and 5 th October 2020 with confirmed or highly suspected SARS-CoV-2 infection at 31 UK centres, who consented to be contacted for follow-up studies, who completed a follow-up questionnaire, and who were discharged at least 90 days ago at the time of data collection were eligible for inclusion. Patients who did not survive to follow-up were excluded. We restricted this secondary analysis to patients who received IMV.

Following Intensive Care Discharge (RECOVER) trial:

Patients aged 18 and over, discharged from ICU between 1 st December 2010 and 31 st January 2013 at 2 hospitals in Edinburgh, Scotland, who received a minimum of 48-hours of IMV 21 . Patients randomised to the intervention group received enhanced hospital and community-based physical rehabilitation, the control group received routine care 21 . Both groups were included in this analysis, as there were no significant differences at baseline or follow-up 21 .

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

Both studies used patient-completed questionnaires to collect outcome data 11, 21 . CCP-UK completed follow-up assessment via postal questionnaires (or telephone where this was not possible), which patients completed once and returned 11 . RECOVER completed follow-up assessment face-to-face or by telephone at 3-months, and by post at 6 and 12-months posthospital discharge 21 .

In this secondary analysis, the primary outcome was patient-reported fatigue severity.

Secondary outcomes were: 'severe fatigue', breathlessness, and measures of health-related QOL.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Covid-19 IMV-patients were compared to the pre-pandemic IMV-patients at baseline, follow-up, and potential associations with outcomes within each group were compared.

Covid-19 and pre-pandemic IMV-patients were compared at baseline in terms of age, sex, prior comorbidity, deprivation. Fatigue severity and the prevalence of severe fatigue was compared. Fatigue in Covid-19 IMV-patients was stratified by time since hospital discharge that patients responded to the CCP-UK questionnaire: approximately 3 (90-120 days) and 6-. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Categorical data were summarised as frequencies and percentages, continuous data as median and interquartile range (IQR). To test for differences across comparison groups in categorical data, we used Fisher's exact test and for continuous data, using the Wilcoxon rank-sum test for two-sample testing and Kruskall-Wallis where there were more than 2 groups.

We created linear regression models to adjust for age, sex, presence of comorbidities, and acute illness severity, for the outcomes of fatigue severity, breathlessness, and QOL in the Covid-19 and the pre-pandemic IMV-patient groups. Final model selection was guided by minimisation of the Akaike information criterion (AIC). Variables were only included in the model if they were present during the initial hospital admission. All models were checked for first order interactions and any meaningful interactions were retained and incorporated as dummy variables. In the Covid-19 cohort, we adjusted for the effects of age by sex, as this was identified as a significant interaction. Effect estimates are presented as mean differences alongside 95% confidence intervals (95%-CI). Statistical analyses were performed using R version 3.6.3 (R Foundation for Statistical Computing, Vienna, AUT) with . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.15.21258879 doi: medRxiv preprint the tidyverse, finalfit, eq5d and Hmisc packages. Statistical significance was taken at the level P≤0.05. Associations with outcomes were compared between the groups, for example to determine if age differences existed in both the Covid-19 and pre-pandemic groups.

We created an ordinal logistic regression and a logistic regression model including all patients (Covid-19 and pre-pandemic group), to adjust for age, sex, presence of comorbidities, and Covid-19 status on fatigue: with ordinal regression we explored fatigue in categories: 0-2/10, 2-4/10, 4-6/10, 6-8/10, 8-10/10, and with logistic regression we explored more severe reported fatigue, taking scores less than or equal to 7/10 or not as a binary outcome. Pre-pandemic outcomes at 6 months were included.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. IMV-patients responded a median 185 days, IQR:137 to 241, after hospital discharge (Table-1 ).

Pre-pandemic IMV-patients received a median 8 days of IMV, IQR:5 to 15; the median APACHE-II score was 20, IQR:16 to 25 (Table-1) .

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021.

The median fatigue severity reported by Covid-19 IMV-patients at the timepoint they responded was 5.0, (n= 85), IQR:2.0 to 7.0, Table-2) . At 3-months, fatigue severity was similar between Covid-19 (n=18) and pre-pandemic IMV-patients (n=188). At 6-months, prepandemic IMV-patients (n=166) reported significantly greater fatigue than Covid-19 IMVpatients (n=29), median 5.7/10, IQR:3.5 to 7.3/10 vs median 2/10, IQR:1.0 to 5.0/10, p<0.001).

Fatigue at 12-months was not compared because Covid-19 IMV-patients had not accrued follow-up to this time point.

Severe fatigue at the timepoint they responded was reported in 28.2% [24/85] 

The median MRC grade reported by Covid-19 IMV-patients was 2/5, IQR:1 to 3 (Table 4 ). At 6-months, the median breathlessness VAS score reported by pre-pandemic IMV-patients was 3.6/10, IQR:1.2 to 6.0 (Supplementary Table- 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. In Covid-19 IMV-patients, females younger than 50 were nearly 3 times more likely to report greater fatigue (adjusted mean difference 2.56, 95%CI:-0.25 to 5.36, p=0.037). Having prior comorbidity was associated with worse fatigue and QOL (Table-3a ).

In pre-pandemic IMV-patients, sex and duration of IMV showed no significant effect on any outcomes included at 3-12 months (Table-3b, Supplementary Table- . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. illness survivors experienced high levels of fatigue, breathlessness, and poor QOL, adding to existing evidence that finding the best rehabilitation services to support ICU-survivors is a research priority 4,5 . In our study, the difference in fatigue prevalence and severity at 6months, and the difference in factors associated with worse fatigue (female sex), suggest that the recovery trajectory from Covid-19 critical illness may be different to general PICS. Covid-19 critical illness survivors are also more likely to suffer additional respiratory sequelae 31 . In our analysis patients who survived Covid-19 were younger with less prior comorbidity than those surviving other critical illness -this may explain why less fatigue at 6-months was reported after Covid-19 critical illness, as coping with the challenges of comorbidity has been identified as a barrier to ICU-recovery 29, 30 . The lower fatigue in Covid-19 patients at 6-months is surprising as Covid-19 patients may have been expected to suffer worse fatigue than prepandemic patients if they were more likely to be discharged at a lower functional level due to greater high-demand for ICU beds throughout the pandemic and a focus on survival as opposed to rehabilitation. A multitude of different factors interact to drive fatigue in critical . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.15.21258879 doi: medRxiv preprint illness survivors, including deconditioning secondary to extended immobilisation, anaemia, poor sleep, depression, post-traumatic stress, respiratory illness (which may be due to prolonged ventilation), chronic disease, and drugs 1, 18, 29, [32] [33] [34] [35] . It is possible that once acute illness severity exceeds the threshold for requiring IMV and ICU-admission, further illness severity and underlying disease have little impact on persistent fatigue. This is consistent with recent research which found that post-ICU rehabilitation requirements were unaffected by Covid-19 infection status 36 .

Our study adds to existing literature by highlighting sex differences in recovery from critical illness that are unique to Covid-19. Our finding that women under 50 who survived hospitalisation with acute-Covid-19 experienced worse symptoms and QOL is consistent with other recent evidence in hospitalised cohorts 9,11,12. Our study corroborates this in IMV-patients, as previous studies in China and Russia captured small proportions of patients requiring critical care (1% 16 and 2.6% 12 respectively).

It is unclear why women under 50 experienced worse fatigue after Covid-19 critical illness. Men may have been more likely to underreport symptoms 37 , but this was not seen in our pre-pandemic control. Women may have been more likely to survive severe acute-Covid-19 disease and therefore to live with worse long-term sequelae 6 , however in our data men survived more severe acute disease. Younger women may have had higher initial exposure to Covid-19, where women are more likely to work in occupations with greater exposure 38 . There are likely to be sex differences in the immune system-response to Covid-19 as susceptibility to severe disease is a consistent feature in many studies 39 . More research is indicated to elucidate why younger women experience worse long-term outcomes, and if they should be prioritised in vaccination programmes, particularly as the . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. Our data provides important insights into these complex syndromes, which need far greater research to assess the true impact they have on patients. To our knowledge, no previous study has included an appropriate control group with similar illness severity to a Covid-19

cohort. There are several important limitations to our study that must be considered. Firstly, our findings may be subject to responder and survivor bias. The sample sizes included by both CCP-UK and RECOVER were relatively small, and individuals with milder symptoms may have felt less compelled to respond, and those with the most severe symptoms or who died would have been unable to respond. We controlled for CCP-UK and RECOVER measuring outcomes at different timepoints by stratifying fatigue by time since hospital discharge, which allowed equivalent timepoints to be compared but further restricted sample sizes.

Secondly, our results may not be fully representative of all survivors of Covid-19 or non-Covid critical illness, as only patients admitted to a few UK hospitals were included (31 hospitals in CCP-UK, 2 in RECOVER). Thirdly, as CCP-UK and RECOVER did not use the same outcome measures, we were unable to explore differences in acute illness severity . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. Tables and Figures   . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.15.21258879 doi: medRxiv preprint

Post-intensive care syndrome: An overview

Five-Year Mortality and Hospital Costs Associated with Surviving Intensive Care

A UK survey of rehabilitation following critical illness: implementation of NICE Clinical Guidance 83 (CG83) following hospital discharge

Rehabilitation after critical illness in adults. NICE guidance

The Priority Setting Partnerships (Online). Intensive Care Top 10

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies

COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE study

Three-Month Outcome in Survivors of COVID-19

Associated Acute Respiratory Distress Syndrome. Prepr with Lancet. Epub ahead of print 2021

Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Epub ahead of print 2021

Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study

Persistent Symptoms in Patients After Acute COVID-19

Post-Ebola Syndrome

The Uncertainty Surrounding the Burden of Postacute Consequences of Dengue Infection

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Attributes and predictors of long COVID

Prevalence and experience of fatigue in survivors of critical illness: a mixed-methods systematic review

Intensive care unit survivorship' -a constructivist grounded theory of surviving critical illness

Long term follow-up of quality of life and functional ability in patients with ICU acquired Weakness -A post hoc analysis

Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial

A minimal common outcome measure set for COVID-19 clinical research

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II in predicting hospital mortality of neurosurgical intensive care unit patients

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Medical Research Council. 1952 MRC Breathlessness Scale

EQ-5D-3L User Guide

Short Form 12 Health Survey (SF-12) BT -Encyclopedia of Quality of Life and Well-Being Research

Unplanned early hospital readmission among critical care survivors: a mixed methods study of patients and carers

Predicting risk of unplanned hospital readmission in survivors of critical illness: a population-level cohort study

Rehabilitation Levels in Patients with COVID-19 Admitted to Intensive Care Requiring Invasive Ventilation. An Observational Study

Best practice in critical care: anaemia in acute and critical illness

Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study

A framework for diagnosing and classifying intensive care unit-acquired weakness

Sleep Deprivation in Intensive Care Unit -Systematic Review